Premetastatic niche formation in the liver: emerging mechanisms and mouse models

Verfasser / Beitragende:
[Achim Krüger]
Ort, Verlag, Jahr:
2015
Enthalten in:
Journal of Molecular Medicine, 93/11(2015-11-01), 1193-1201
Format:
Artikel (online)
ID: 605544069
LEADER caa a22 4500
001 605544069
003 CHVBK
005 20210128100929.0
007 cr unu---uuuuu
008 210128e20151101xx s 000 0 eng
024 7 0 |a 10.1007/s00109-015-1342-7  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s00109-015-1342-7 
100 1 |a Krüger  |D Achim  |u Institut für Molekulare Immunologie und Experimentelle Onkologie, Klinikum rechts der Isar der Technischen Universität München|, Ismaninger Str. 22, D-81675, München, Germany  |4 aut 
245 1 0 |a Premetastatic niche formation in the liver: emerging mechanisms and mouse models  |h [Elektronische Daten]  |c [Achim Krüger] 
520 3 |a The liver is recognized as the target organ of metastases of almost all prominent malignancies. Its unique biology renders this organ particularly susceptible to circulating disseminated tumour cells (DTCs), and it can be assumed that very early metastasis occurs in the liver. The premetastatic niche concept may explain very early metastasis, as it defines priming of a future target organ of metastasis by factors that may already be secreted from premalignant lesions. This review shows that comprehensive knowledge on mechanisms of premetastatic niche formation in the liver is based on pre-clinical models only and still rather rare, mostly due to the scarcity of mouse liver metastasis models displaying a tumour cell-free period in the liver or lack of liver-tropic syngeneic tumour cells to probe for the niche. Attentive re-assessment of previous studies and reviews was undertaken revealing only two clearly identified tumour-derived secreted factors (TDSFs), both inducing infiltration of the liver by bone marrow-derived cells and increased liver metastasis, namely tissue inhibitor of metalloproteinases-1 (TIMP-1) and macrophage-inducing factor (MIF). Future directions of this research area will comprise elucidation of the impact of TDSFs on regulation and activity of myeloid-derived suppressor cells and/or the specific architecture and homeostasis of the liver, as well as development of prognostic TDSF detection in patients at risk of liver metastasis. 
540 |a Springer-Verlag Berlin Heidelberg, 2015 
690 7 |a Liver metastasis  |2 nationallicence 
690 7 |a Premetastatic niche  |2 nationallicence 
690 7 |a Sinusoids  |2 nationallicence 
690 7 |a MDSCs  |2 nationallicence 
690 7 |a TIMP-1  |2 nationallicence 
690 7 |a MIF  |2 nationallicence 
773 0 |t Journal of Molecular Medicine  |d Springer Berlin Heidelberg  |g 93/11(2015-11-01), 1193-1201  |x 0946-2716  |q 93:11<1193  |1 2015  |2 93  |o 109 
856 4 0 |u https://doi.org/10.1007/s00109-015-1342-7  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a review-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s00109-015-1342-7  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 100  |E 1-  |a Krüger  |D Achim  |u Institut für Molekulare Immunologie und Experimentelle Onkologie, Klinikum rechts der Isar der Technischen Universität München|, Ismaninger Str. 22, D-81675, München, Germany  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Journal of Molecular Medicine  |d Springer Berlin Heidelberg  |g 93/11(2015-11-01), 1193-1201  |x 0946-2716  |q 93:11<1193  |1 2015  |2 93  |o 109